{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:29:46Z","timestamp":1760956186308,"version":"build-2065373602"},"reference-count":44,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Purpose: For adjuvant radiotherapy of low-risk breast cancer after breast-conserving surgery, there have been many trials of hypofractionation and partial breast irradiation (PBI) over the years, with proven mild long-term toxicity. The aim of this study was to introduce a short-course dose-adapted concept, proven in whole breast irradiation (WBI) for use in accelerated partial breast irradiation (APBI), while monitoring dosimetric data and toxicity. Methods: From April 2020 to March 2022, 61 patients with low-risk breast cancer or ductal carcinoma in situ (DCIS) were treated at a single institution with percutaneous APBI of 26 Gy in five fractions every other day after breast-conserving surgery. Dosimetric data for target volume and organs at risk were determined retrospectively. Acute toxicity was evaluated. Results: The target volume of radiotherapy comprised an average of 19% of the ipsilateral mamma. The burden on the heart and lungs was very low. The mean cardiac dose during irradiation of the left breast was only 0.6 Gy. Two out of three patients remained without any acute side effects. Conclusions: Linac-based APBI is an attractive treatment option for patients with low-risk breast cancer in whom neither WBI nor complete omission of radiotherapy appears to be an adequate alternative.<\/jats:p>","DOI":"10.3390\/cancers15041138","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T03:52:49Z","timestamp":1676001169000},"page":"1138","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Linac-Based Ultrahypofractionated Partial Breast Irradiation (APBI) in Low-Risk Breast Cancer: First Results of a Monoinstitutional Observational Analysis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2897-4064","authenticated-orcid":false,"given":"Roland","family":"Merten","sequence":"first","affiliation":[{"name":"Clinic for Radiotherapy, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirko","family":"Fischer","sequence":"additional","affiliation":[{"name":"Clinic for Radiotherapy, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gennadii","family":"Kopytsia","sequence":"additional","affiliation":[{"name":"Clinic for Radiotherapy, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rn","family":"Wichmann","sequence":"additional","affiliation":[{"name":"Clinic for Radiotherapy, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Lange","sequence":"additional","affiliation":[{"name":"Clinic for Radiotherapy, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Caroline","family":"Kn\u00f6chelmann","sequence":"additional","affiliation":[{"name":"Clinic for Radiotherapy, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6972-0899","authenticated-orcid":false,"given":"Jan-Niklas","family":"Becker","sequence":"additional","affiliation":[{"name":"Clinic for Radiotherapy, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0117-4366","authenticated-orcid":false,"given":"R\u00fcdiger","family":"Klapdor","sequence":"additional","affiliation":[{"name":"Clinic for Gynecology and Obstetrics, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0135-7082","authenticated-orcid":false,"given":"Jan","family":"Hinrichs","sequence":"additional","affiliation":[{"name":"Institute for Radiology, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bremer","sequence":"additional","affiliation":[{"name":"Clinic for Radiotherapy, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2005.01.005","article-title":"Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: Long-term results of a randomised trial","volume":"75","author":"Yarnold","year":"2005","journal-title":"Radiother. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jamaoncol.2015.2666","article-title":"Acute and short-term toxic effects of conventionally fractionated vs hypofractionated whole-breast irradiation: A randomized clinical trial","volume":"1","author":"Shaitelman","year":"2015","journal-title":"JAMA Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK standardisation of breast radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/S0140-6736(19)32515-2","article-title":"External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): A randomised controlled trial","volume":"394","author":"Whelan","year":"2019","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.radonc.2010.01.014","article-title":"Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the groupe Europ\u00e9en de curieth\u00e9rapie-European society for therapeutic radiology and oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009)","volume":"94","author":"Polo","year":"2010","journal-title":"Radiother. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1470-2045(13)70497-2","article-title":"Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): A randomised controlled equivalence trial","volume":"14","author":"Veronesi","year":"2013","journal-title":"Lancet Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(13)61950-9","article-title":"Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial","volume":"383","author":"Vaidya","year":"2014","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(15)00471-7","article-title":"5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: A randomised, phase 3, non-inferiority trial","volume":"387","author":"Strnad","year":"2016","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ejca.2014.12.013","article-title":"Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial","volume":"51","author":"Livi","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1200\/JCO.20.00650","article-title":"Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: Long-term results of the randomized phase III APBI-IMRT-florence trial","volume":"38","author":"Meattini","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/S0140-6736(19)32514-0","article-title":"Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: A randomised, phase 3, equivalence trial","volume":"394","author":"Vicini","year":"2019","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Brunt","year":"2020","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"LBA501","DOI":"10.1200\/JCO.2022.40.17_suppl.LBA501","article-title":"LUMINA: A prospective trial omitting radiotherapy (RT) following breast conserving surgery (BCS) in T1N0 luminal A breast cancer (BC)","volume":"40","author":"Whelan","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1245\/s10434-010-1192-z","article-title":"Update on DCIS outcomes from the American society of breast surgeons accelerated partial breast irradiation registry trial","volume":"18","author":"Jeruss","year":"2011","journal-title":"Ann. Surg. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Brierley, J.D., Gospodarowicz, M.K., and Wittekind, C. (2017). TNM Classification of Malignant Tumours, Wiley.","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00066-020-01613-z","article-title":"DEGRO practical guideline for partial-breast irradiation","volume":"196","author":"Strnad","year":"2020","journal-title":"Strahlenther. Onkol."},{"key":"ref_17","unstructured":"ICRU (1993). ICRU Report 50: Prescribing, Recording, and Reporting Photon Beam Therapy, ICRU."},{"key":"ref_18","unstructured":"ICRU (1999). ICRU Report 62: Prescribing, Recording, and Reporting Photon Beam Therapy, ICRU."},{"key":"ref_19","unstructured":"ICRU (2010). ICRU Report 83: Prescribing, Recording and Reporting Photon-Beam Intensity-Modulated Radiation Therapy (IMRT), ICRU."},{"key":"ref_20","unstructured":"National Cancer Institute (2017). Common Terminology Criteria for Adverse Events (CTCAE), National Cancer Institute."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0360-3016(96)00601-3","article-title":"A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: Application to the prostate","volume":"37","author":"Mak","year":"1997","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_22","unstructured":"German Guideline Program in Oncology (2021). Evidence-Based Guideline Breast Cancer\u2014V4.4, GGPO."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S1470-2045(21)00539-8","article-title":"European society for radiotherapy and oncology advisory committee in radiation oncology practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer","volume":"23","author":"Meattini","year":"2022","journal-title":"Lancet Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000516419","article-title":"AGO recommendations for the diagnosis and treatment of patients with early breast cancer: Update 2021","volume":"16","author":"Ditsch","year":"2021","journal-title":"Breast Care"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1200\/JCO.19.02750","article-title":"Ten-year results of FAST: A randomized controlled trial of 5-fraction whole-breast radiotherapy for early breast cancer","volume":"38","author":"Brunt","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijrobp.2010.01.020","article-title":"Accelerated partial breast irradiation: 5-year results of the German-Austrian multicenter phase II trial using interstitial multicatheter brachytherapy alone after breast-conserving surgery","volume":"80","author":"Strnad","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_27","unstructured":"National Institute for Health and Care Excellence (2018). Early and Locally Advanced Breast Cancer: Diagnosis and Management, NICE."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1748-717X-5-90","article-title":"Accelerated partial breast irradiation (APBI): A review of available techniques","volume":"5","author":"Njeh","year":"2010","journal-title":"Radiat. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00066-019-01495-w","article-title":"Herzschonende strahlentherapietechniken bei brustkrebspatientinnen: Eine stellungnahme des brustkrebs-expertenpanels der deutschen gesellschaft f\u00fcr radioonkologie (DEGRO) (Heart-sparing radiotherapy techniques in breast cancer patients: A recommendation of the breast cancer expert panel of the German society of radiation oncology (DEGRO))","volume":"195","author":"Duma","year":"2019","journal-title":"Strahlenther. Onkol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ijrobp.2018.10.025","article-title":"Radiation dose-response for risk of myocardial infarction in breast cancer survivors","volume":"103","author":"Jacobse","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ijrobp.2009.04.070","article-title":"Accelerated partial breast irradiation with IMRT: New technical approach and interim analysis of acute toxicity in a phase III randomized clinical trial","volume":"77","author":"Livi","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3109\/0284186X.2014.887226","article-title":"Accelerated partial breast irradiation (APBI): Are breath-hold and volumetric radiation therapy techniques useful?","volume":"53","author":"Essers","year":"2014","journal-title":"Acta Oncol."},{"key":"ref_34","first-page":"2475","article-title":"Symptomatic radiation pneumonitis after accelerated partial breast irradiation using three-dimensional conformal radiotherapy","volume":"36","author":"Shikama","year":"2016","journal-title":"Anticancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1200\/JCO.2008.20.0121","article-title":"Lung dose-volume parameters and the risk of pneumonitis for patients treated with accelerated partial-breast irradiation using three-dimensional conformal radiotherapy","volume":"27","author":"Recht","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1080\/0284186X.2021.1976828","article-title":"Pneumonitis and fibrosis after breast cancer radiotherapy: Occurrence and treatment-related predictors","volume":"60","author":"Karlsen","year":"2021","journal-title":"Acta Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijrobp.2016.05.008","article-title":"Reduced mortality with partial-breast irradiation for early breast cancer: A meta-analysis of randomized trials","volume":"96","author":"Vaidya","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.ijrobp.2009.03.012","article-title":"Four-year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation","volume":"76","author":"Chen","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1470-2045(17)30011-6","article-title":"Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial","volume":"18","author":"Ott","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejca.2017.01.023","article-title":"Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the florence phase 3 trial","volume":"76","author":"Meattini","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1470-2045(14)71221-5","article-title":"Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): A randomized controlled trial","volume":"16","author":"Kunkler","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: Long-term follow-up of CALGB 9343","volume":"31","author":"Hughes","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijrobp.2022.09.062","article-title":"A meta-analysis of trials of partial breast irradiation","volume":"115","author":"Goldberg","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Ott, O.J., Stillkrieg, W., Lambrecht, U., Sauer, T.O., Schweizer, C., Lamrani, A., Strnad, V., Hack, C.C., Beckmann, M.W., and Uder, M. (2022). External beam accelerated partial breast irradiation in early breast cancer and the risk for radiogenic pneumonitis. Cancers, 14.","DOI":"10.3390\/cancers14143520"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/4\/1138\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:29:59Z","timestamp":1760120999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/4\/1138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,10]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["cancers15041138"],"URL":"https:\/\/doi.org\/10.3390\/cancers15041138","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2023,2,10]]}}}